COMBINATION OF ITRIGLUMIDE AND PROTON PUMP INHIBITORS IN THE TREATMENT OF GASTROINTESTINAL AND RELATED DISORDERS

The invention relates to the combination of the cholecystokinin-2 (CCK-2) receptor antagonist Itriglumide and proton pump inhibitors (PPIs) for the treatment of patients suffering from gastrointestinal and related disorders.

Saved in:
Bibliographic Details
Main Authors D'AMATO, MASSIMO MARIA, GIORDANI, ANTONIO, ROVATI, LUCIO CLAUDIO, CASELLI, GIANFRANCO, MAKOVEC, FRANCESCO
Format Patent
LanguageEnglish
French
Published 21.01.2014
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the combination of the cholecystokinin-2 (CCK-2) receptor antagonist Itriglumide and proton pump inhibitors (PPIs) for the treatment of patients suffering from gastrointestinal and related disorders.
Bibliography:Application Number: CA20062616941